Home › Trial NCT02341989
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
- Trial IDNCT02341989
- StatusActive Not Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorSt. Olavs Hospital
- Enrollment348
- Start date2015-04-08
- ConditionsTesticular Neoplasms · Seminoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.